Shruti Lal, Ph.D.
Affiliations: | 2011 | Genetics, Genomics and Bioinformatics | University of California, Riverside, Riverside, CA, United States |
Area:
Molecular Biology, Genetics, Bioinformatics BiologyGoogle:
"Shruti Lal"Parents
Sign in to add mentor| Harley Smith | grad student | 2011 | UC Riverside | |
| (Integration of Molecular Networks in the Shoot Apical Meristem that Controls Floral Specification in Arabidopsis thaliana.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zarei M, Lal S, Vaziri-Gohar A, et al. (2018) RNA-binding Protein HuR Regulates Both Mutant and Wild-type IDH1 in IDH1-mutated Cancer. Molecular Cancer Research : McR |
| Chand SN, Zarei M, Schiewer MJ, et al. (2017) Post-transcriptional regulation of PARG mRNA by HuR facilitates DNA repair and resistance to PARP inhibitors. Cancer Research |
| Zarei M, Lal S, Parker SJ, et al. (2017) Posttranscriptional upregulation of IDH1 by HuR establishes a powerful survival phenotype in pancreatic cancer cells. Cancer Research |
| Lal S, Cheung EC, Zarei M, et al. (2017) CRISPR Knockout of the HuR Gene Causes a Xenograft Lethal Phenotype. Molecular Cancer Research : McR |
| Lal S, Zarei M, Chand SN, et al. (2016) WEE1 inhibition in pancreatic cancer cells is dependent on DNA repair status in a context dependent manner. Scientific Reports. 6: 33323 |
| Cheung E, Lal S, Zarei M, et al. (2016) Abstract 2854: CRISPR knockout of HuR in pancreatic cancer cells causes a xenograft lethal phenotype Cancer Research. 76: 2854-2854 |
| Zarei M, Lal S, Mambelli-Lisboa NC, et al. (2016) Abstract 1847: The mRNA-binding protein HuR, regulates mutant and wild type IDH1 expression in IDH1-mutated cancer Cancer Research. 76: 1847-1847 |
| Cozzitorto JA, Jimbo M, Chand S, et al. (2015) Studying RNA-binding protein interactions with target mRNAs in eukaryotic cells: native ribonucleoprotein immunoprecipitation (RIP) assays. Methods in Molecular Biology (Clifton, N.J.). 1262: 239-46 |
| Tholey RM, Lal S, Jimbo M, et al. (2015) MUC1 Promoter-Driven DTA as a Targeted Therapeutic Strategy against Pancreatic Cancer. Molecular Cancer Research : McR. 13: 439-48 |
| Lal S, Chand SN, Dylgjeri E, et al. (2015) Abstract 1656: MK-1775 (WEE1 inhibition) lacks efficacy against DNA repair deficient pancreatic cancer cells Cancer Research. 75: 1656-1656 |